A Comparison of the Effectiveness and Safety of ULTRACET® (Tramadol Hydrochloride/Acetaminophen) Versus ULTRAM® (Tramadol Hydrochloride) Versus Placebo in Patients With Pain After Oral Surgery
NCT ID: NCT00236483
Last Updated: 2011-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
456 participants
INTERVENTIONAL
2002-11-30
2003-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Intrathecal Nalbuphine Versus Intrathecal Tramadol as Adjuvants in Subarachnoid Block for Lower Limb Orthopaedic Surgeries
NCT07294352
Comparison of Post-Operative Analgesia After Percutaneous Nephrolithotomy.
NCT04835116
Adjuvant Analgesic Effects of Low Dose Tramadol/Acetaminophen Combination After Open Gynaecological Surgery
NCT00942565
Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
NCT03774836
Intravenous Paracetamol for Postoperative Pain
NCT02248493
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2 capsules, total dose either tramadol HCl 75 milligrams/acetaminophen 650 milligrams, tramadol HCl 100 milligrams, or matching placebo taken one time orally; all study medication is over-capsulated to match.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
tramadol hydrochloride + acetaminophen
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least moderate pain within 5 hours after oral surgery procedure
* Sufficiently alert to follow directions, communicate with study personnel and perform study procedures
* If female, using an acceptable method of birth control and has a negative urine pregnancy test
Exclusion Criteria
* Patients who have had inadequate pain relief from tramadol HCl/acetaminophen or tramadol
* Patients who have used pain medication (other than anesthesia) within 24 hours of receiving study medication, any long-acting over-the-counter pain medications within 3 days, or any pain medication after finishing oral surgery
* Patients with known problems with taking opioid medications or acetaminophen
* Patients with a history of abusing drugs or alcohol
* Patients with an uncontrolled medical condition
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
PriCara, Unit of Ortho-McNeil, Inc.
INDUSTRY
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. Clinical Trial
Role: STUDY_DIRECTOR
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
References
Explore related publications, articles, or registry entries linked to this study.
Fricke JR Jr, Hewitt DJ, Jordan DM, Fisher A, Rosenthal NR. A double-blind placebo-controlled comparison of tramadol/acetaminophen and tramadol in patients with postoperative dental pain. Pain. 2004 Jun;109(3):250-257. doi: 10.1016/j.pain.2004.01.004.
Related Links
Access external resources that provide additional context or updates about the study.
A COMPARISON OF THE EFFICACY AND SAFETY OF ULTRACET (TRAMADOL HCL/ACETAMINOPHEN) VERSUS ULTRAM® (TRAMADOL HCL) VERSUS PLACEBO IN SUBJECTS WITH PAIN FOLLOWING ORAL SURGERY
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR002806
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.